BRCA1 and Lynch syndrome: Regarding geographical distribution, BRCA1/2 testing was mostly provided in the UK (29; 49%) and the USA (11; 19%), Lynch syndrome testing in the UK (6; 26%), and the newborn screening panel in the USA (9; 50%).